Shenyang Pharmaceutical University
Records under this name other than the patents Shenyang Pharmaceutical University holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 9 of 9 · Back to Shenyang Pharmaceutical University
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,730,898 | Compound and use thereof and platinum complex and lipidosome thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,718,837 | Nitrogen-containing heterocyclic ring substituted dihydroartemisinin derivatives and use thereof Lapsed on the fee record Ended Aug 1, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 1, 2025 | USPTO record |
| US 9,127,075 | Analgesic active peptide VGG, preparation and use thereof Lapsed on the fee record Ended Sep 8, 2023 · USPTO record | Lapsed on the fee record | Ended Sep 8, 2023 | USPTO record |
| US 7,098,364 | Phenylethanolamine compounds as β2-receptor agonists, and methods of use and preparation thereof Term ended Term ended Mar 10, 2023 · USPTO record | Term ended | Term ended Mar 10, 2023 | USPTO record |
| US 7,592,309 | Method of using a peptide having analgesic and antitumor activity from scorpion Term ended Term ended Jan 6, 2023 · USPTO record | Term ended | Term ended Jan 6, 2023 | USPTO record |
| US 8,349,835 | Aromatic ring fused triazine derivatives and uses thereof Lapsed on the fee record Ended Jan 8, 2021 · USPTO record | Lapsed on the fee record | Ended Jan 8, 2021 | USPTO record |
| US 9,382,232 | Quinoline and cinnoline derivatives and their applications Lapsed on the fee record Ended Jul 5, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 5, 2020 | USPTO record |
| US 8,415,505 | 2-methylene-5-substituted-methylenecyclopentanone derivatives and use thereof Lapsed on the fee record Ended Apr 9, 2017 · USPTO record | Lapsed on the fee record | Ended Apr 9, 2017 | USPTO record |
| US 7,960,427 | 5-hydroxyindole-3-carboxylate derivatives and uses thereof Lapsed on the fee record Ended Jun 14, 2015 · USPTO record | Lapsed on the fee record | Ended Jun 14, 2015 | USPTO record |